+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Beta Interferon Market - Global Forecast 2025-2032 - Product Thumbnail Image

Beta Interferon Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
Oligonucleotide Therapeutics Market 2024-2028 - Product Thumbnail Image

Oligonucleotide Therapeutics Market 2024-2028

  • Report
  • April 2024
  • 169 Pages
  • Global
From
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a Landscape Analysis of Technologies, Targets, Business and Financing from An Industry Perspective - Product Thumbnail Image

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a Landscape Analysis of Technologies, Targets, Business and Financing from An Industry Perspective

  • Report
  • November 2022
  • 418 Pages
  • Global
From
Antivirals Market Report 2025 - Product Thumbnail Image

Antivirals Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market Report 2025 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Central Nervous System Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Central Nervous System Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
Porokeratosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Porokeratosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • April 2023
  • 116 Pages
  • Global
From
Biosimilars Market Report and Forecast 2023-2031 - Product Thumbnail Image

Biosimilars Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Injections for SMA Market - Global Forecast 2025-2030 - Product Thumbnail Image

Injections for SMA Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Lecanemab Injection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lecanemab Injection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
Ethical Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Ethical Pharmaceuticals Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Diphtheria Market Report 2025 - Product Thumbnail Image

Diphtheria Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Gene Therapies & Associated Vectors: Intellectual Property Landscape - Product Thumbnail Image

Gene Therapies & Associated Vectors: Intellectual Property Landscape

  • Report
  • April 2022
  • 131 Pages
  • Global
From
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups

  • Report
  • May 2024
  • 50 Pages
  • Canada
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition - The Views of 87 UK Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition - The Views of 87 UK Patient Groups

  • Report
  • May 2024
  • 59 Pages
  • United Kingdom
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups

  • Report
  • May 2024
  • 50 Pages
  • United States
The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide

  • Report
  • April 2024
  • 138 Pages
  • Global
Granulomatosis With Polyangiitis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Granulomatosis With Polyangiitis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Report 2025 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Loading Indicator